In patients with NASH and T2DM, PGZ reduces hepatic steatosis, inflammation, and serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) and improves liver fibrosis [86]. This evidence concerns the gene GPT and Hepatic fibrosis.